ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Anonymous $100 Million Gift Moves OHSU Within $82 Million Of Reaching $1 Billion Goal

August 1, 2014

CCOP Review Committees Listed

February 6, 1987

Blumenthal Says Action Plan To Issue “New Priority Areas”

October 24, 1996

In Brief: Friedell To Head McDowell Network, New Kentucky Cancer Center; Nine Expiring Core Grants Approved

October 29, 1982

CIS Celebrates 15th Anniversary, Praised By M. Quayle

December 6, 1991

Sen. Grassley Presses Amgen on “Bundling.”

April 11, 2008